The US Oncology Network finds cancer drug may benefit advanced COVID-19 patients
HOUSTON: Rapid improvements have been seen in acutely ill patients with COVID-19 treated with the cancer drug acalabrutinib (Calquence) by researchers, including physicians within The...
Bevespi Aerosphere approved in China for patients with COPD
LONDON: AstraZeneca’s Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in China as a maintenance treatment to relieve symptoms in patients with chronic obstructive pulmonary disease...
DeepMatter collaborates with AstraZeneca to improve productivity of compound synthesis
LONDON: DeepMatter Group has collaborated with AstraZeneca to use innovative digital technologies with the aim of improving the productivity and reproducibility of compound synthesis. DeepMatter’s...
AstraZeneca divests rights to Seroquel and Seroquel XR for $35 million
LONDON, UK: AstraZeneca has agreed to sell the commercial rights to Seroquel and Seroquel XR in the US and Canada to Cheplapharm Arzneimittel GmbH. Cheplapharm...